BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//EAHAD - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:EAHAD
X-ORIGINAL-URL:https://www.eahad.org
X-WR-CALDESC:Events for EAHAD
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Brussels
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260406
DTEND;VALUE=DATE:20260407
DTSTAMP:20260506T170451
CREATED:20260409T133628Z
LAST-MODIFIED:20260409T133628Z
UID:30993-1775433600-1775519999@www.eahad.org
SUMMARY:Revisiting the role of FVIII in Haemophilia A in 2026
DESCRIPTION:Cedric Hermans sits down with Jan Blatný\, Consultant Haematologist at Masaryk University and University Hospital Brno\, EHCC and EuroBloodNet Centre\, and former EAHAD President (2024–2026)\, to explore the evolving role of Factor VIII in the management of haemophilia A in 2026. As new therapies such as emicizumab\, rebalancing agents\, and gene therapy reshape the treatment landscape\, this conversation revisits where FVIII remains essential.
URL:https://www.eahad.org/event/revisiting-the-role-of-fviii-in-haemophilia-a-in-2026/
LOCATION:EAHAD Academy
CATEGORIES:2026,Events
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20260407T173000
DTEND;TZID=Europe/Brussels:20260407T183000
DTSTAMP:20260506T170451
CREATED:20260409T132716Z
LAST-MODIFIED:20260409T132845Z
UID:30976-1775583000-1775586600@www.eahad.org
SUMMARY:Clinical Implications of Roctavian’s Market Withdrawal
DESCRIPTION:The recent withdrawal of Roctavian from the market has raised important questions for clinicians\, patients\, and healthcare systems involved in the management of haemophilia A gene therapy. As the first approved GT  medicine for adults with severe haemophilia A\, Roctavian represented a significant milestone in the evolution of treatment options\, and the effects of its withdrawal remain to be seen. This online session explores the clinical implications of its withdrawal\, including considerations for patient management\, ongoing monitoring of treated individuals\, and the broader impact on the future of gene therapy in haemophilia. \n\n\n\n\nWatch this insightful discussion on what this development means for clinical practice and the haemophilia community.
URL:https://www.eahad.org/event/clinical-implications-of-roctavians-market-withdrawal/
LOCATION:Online
CATEGORIES:2026,Events
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260410
DTEND;VALUE=DATE:20260411
DTSTAMP:20260506T170451
CREATED:20260409T132557Z
LAST-MODIFIED:20260409T133746Z
UID:30972-1775779200-1775865599@www.eahad.org
SUMMARY:E-Learning Module 22: Connecting the Dots: How Hemophilia Guidelines Drive Practice\, Policy\, and Access
DESCRIPTION:
URL:https://www.eahad.org/event/e-learning-module-22-connecting-the-dots-how-hemophilia-guidelines-drive-practice-policy-and-access/
LOCATION:EAHAD Academy
CATEGORIES:2026,Events
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260410
DTEND;VALUE=DATE:20260417
DTSTAMP:20260506T170451
CREATED:20251020T173956Z
LAST-MODIFIED:20251020T175041Z
UID:30415-1775779200-1776383999@www.eahad.org
SUMMARY:WFH Congress
DESCRIPTION:The WFH 2026 World Congress will include over 80 hours of continuing educational sessions across the Medical and People with Bleeding Disorders (PWBD) tracks\, as well as six professional development tracks: Nursing\, Dental\, Laboratory Sciences\, Psychosocial\, Musculoskeletal (MSK) and Women and Girls with Bleeding Disorders (WGBD).
URL:https://www.eahad.org/event/wfh-congress/
LOCATION:Kuala Lumpur\, Malaysia\, Malaysia
CATEGORIES:Nurses
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260611
DTEND;VALUE=DATE:20260615
DTSTAMP:20260506T170451
CREATED:20251020T174146Z
LAST-MODIFIED:20251020T174302Z
UID:30419-1781136000-1781481599@www.eahad.org
SUMMARY:EHA2026 Congress
DESCRIPTION:The European Hematology Association (EHA) community consists of doctors (haematologists)\, researchers (PhD or otherwise)\, patients (and advocacy groups)\, geneticists\, nurses\, and more mainly across Europe\, including non-EU member states.
URL:https://www.eahad.org/event/eha2026-congress/
LOCATION:Stockholm\, Sweden\, Sweden
CATEGORIES:Nurses
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20260615T170000
DTEND;TZID=Europe/Brussels:20260615T180000
DTSTAMP:20260506T170451
CREATED:20260406T150040Z
LAST-MODIFIED:20260409T133540Z
UID:30990-1781542800-1781546400@www.eahad.org
SUMMARY:Inhibitor Development in Gene Therapy for Haemophilia
DESCRIPTION:Gene therapy is transforming the treatment landscape of hemophilia\, but major questions remain regarding its use in patients with current or past inhibitors. In this webinar\, leading experts will discuss the most challenging clinical and immunological questions\, from mechanisms of liver-induced tolerance to the management of inhibitors developing after gene transfer\, and will debate whether eligibility criteria should evolve in light of emerging data.
URL:https://www.eahad.org/event/inhibitor-development-in-gene-therapy-for-haemophilia/
LOCATION:Online
CATEGORIES:2026,Events
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260711
DTEND;VALUE=DATE:20260716
DTSTAMP:20260506T170451
CREATED:20251020T174244Z
LAST-MODIFIED:20251020T175020Z
UID:30422-1783728000-1784159999@www.eahad.org
SUMMARY:ISTH 2026
DESCRIPTION:ISTH is a worldwide not-for-profit organization dedicated to advancing the understanding\, prevention\, diagnosis and treatment of conditions related to thrombosis and haemostasis.
URL:https://www.eahad.org/event/isth-2026/
LOCATION:Paris\, France\, France
CATEGORIES:Nurses
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261002
DTEND;VALUE=DATE:20261005
DTSTAMP:20260506T170451
CREATED:20260417T153605Z
LAST-MODIFIED:20260417T153605Z
UID:31028-1790899200-1791158399@www.eahad.org
SUMMARY:EHC Conference 2026
DESCRIPTION:
URL:https://www.eahad.org/event/ehc-conference-2026/
LOCATION:Istambul
CATEGORIES:Nurses
END:VEVENT
END:VCALENDAR